Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00940 | 34923463 | Wiad Lek | INSULIN RESISTANCE AS AN INDICATOR OF DIFFERENTIATION FOR THE FORMATION OF RISK GROUPS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITHOUT TYPE 2 DIABETES MELLITUS, AS A PART OF ONTOLOGICAL MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE. | 2021 | Details |
| A00963 | 34917917 | Metabol Open | Emerging roles for stress kinase p38 and stress hormone fibroblast growth factor 21 in NAFLD development. | 2021 | Details |
| A00968 | 34916558 | Sci Rep | A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight. | 2021 | Details |
| A00976 | 34914039 | Indian J Gastroenterol | Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic fatty liver disease and obesity. | 2021 | Details |
| A00979 | 34911587 | BMC Nutr | Effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial. | 2021 | Details |
| A01017 | 34902220 | J Dig Dis | The importance and impact of recognizing metabolic dysfunction-associated fatty liver disease in patients with chronic hepatitis C. | 2022 | Details |
| A01026 | 34899591 | Front Endocrinol (Lausanne) | Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease. | 2021 | Details |
| A01034 | 34895322 | Stem Cell Res Ther | Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice. | 2021 | Details |
| A01042 | 34893351 | Trends Pharmacol Sci | ER stress in obesity pathogenesis and management. | 2021 | Details |
| A01044 | 34890795 | Clin Gastroenterol Hepatol | 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. | 2021 | Details |
| A01053 | 34887631 | World J Gastroenterol | Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach. | 2021 | Details |
| A01060 | 34884650 | Int J Mol Sci | Verification of the Impact of Blood Glucose Level on Liver Carcinogenesis and the Efficacy of a Dietary Intervention in a Spontaneous Metabolic Syndrome Model. | 2021 | Details |
| A01063 | 34883157 | J Hepatol | Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A01092 | 34871234 | Medicine (Baltimore) | Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome. | 2021 | Details |
| A01095 | 34870551 | Pharm Biol | Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK. | 2022 | Details |
| A01097 | 34870138 | Metabol Open | Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD). | 2021 | Details |
| A01107 | 34867384 | Front Pharmacol | Effects of Nigella sativa, Camellia sinensis, and Allium sativum as Food Additives on Metabolic Disorders, a Literature Review. | 2021 | Details |
| A01117 | 34864598 | Int J Hyg Environ Health | Exposure to polycyclic aromatic hydrocarbons and volatile organic compounds is associated with a risk of obesity and diabetes mellitus among Korean adults: Korean National Environmental Health Survey (KoNEHS) 2015-2017. | 2021 | Details |
| A01118 | 34863942 | Mol Metab | The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease. | 2021 | Details |
| A01140 | 34857244 | Clin Nutr ESPEN | High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus. | 2021 | Details |
| A01144 | 34856688 | Zhonghua Nei Ke Za Zhi | [Correlation between intrahepatic triglyceride content quantified by proton magnetic resonance spectroscopy and glucose metabolism]. | 2021 | Details |
| A01150 | 34853966 | Bull Exp Biol Med | Knockdown of Sirt1 Gene in Mice Results in Lipid Accumulation in the Liver Mediated via PGC-1α-Induced Mitochondrial Dysfunction and Oxidative Stress. | 2021 | Details |
| A01157 | 34849373 | Front Phys | Feasibility of Hepatic Fat Quantification Using Proton Density Fat Fraction by Multi-Echo Chemical-Shift-Encoded MRI at 7T. | 2021 | Details |
| A01158 | 34849196 | Comput Struct Biotechnol J | Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease. | 2021 | Details |
| A01167 | 34847213 | Food Funct | Curcumin supplementation improves biomarkers of oxidative stress and inflammation in conditions of obesity, type 2 diabetes and NAFLD: updating the status of clinical evidence. | 2021 | Details |
| A01183 | 34836332 | Nutrients | Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01189 | 34835937 | Nutrients | Reduced Rank Regression-Derived Dietary Patterns Related to the Fatty Liver Index and Associations with Type 2 Diabetes Mellitus among Ghanaian Populations under Transition: The RODAM Study. | 2021 | Details |
| A01192 | 34833467 | Medicina (Kaunas) | Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients. | 2021 | Details |
| A01196 | 34830997 | Cancers (Basel) | Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach. | 2021 | Details |
| A01215 | 34827579 | Biomolecules | Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms. | 2021 | Details |
| A01237 | 34818080 | Metab Syndr Relat Disord | Increased Serum Pentraxin 3 Is Associated with Prediabetes and Type 2 Diabetes in Obese Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01251 | 34814392 | Zhonghua Gan Zang Bing Za Zhi | [Study on the relationship between non-alcoholic fatty liver disease and sarcopenia in type 2 diabetes mellitus]. | 2021 | Details |
| A01261 | 34810377 | Saudi J Gastroenterol | Association of metabolic traits with occurrence of nonalcoholic fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis of longitudinal cohort studies. | 2022 | Details |
| A01275 | 34805412 | J Diabetes Res | Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus. | 2021 | Details |
| A01296 | 34798335 | Clin Gastroenterol Hepatol | Metabolic Dysfunction-Associated Fatty Liver Disease and Subsequent Development of Adverse Pregnancy Outcomes. | 2021 | Details |
| A01306 | 34794397 | BMC Endocr Disord | Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study. | 2021 | Details |
| A01314 | 34791370 | J Nutr | Dietary and Lifestyle Inflammation Scores Are Inversely Associated with Metabolic-Associated Fatty Liver Disease among Iranian Adults: A Nested Case-Control Study. | 2022 | Details |
| A01335 | 34785918 | Diabetes Metab Syndr Obes | Association Between Aspartate Aminotransferase to Alanine Aminotransferase Ratio and Incidence of Type 2 Diabetes Mellitus in the Japanese Population: A Secondary Analysis of a Retrospective Cohort Study. | 2021 | Details |
| A01337 | 34784620 | Exp Clin Endocrinol Diabetes | Shear Wave Elastography Reveals a High Prevalence of NAFLD-related Fibrosis Even in Type 1 Diabetes. | 2021 | Details |
| A01339 | 34783554 | J Agric Food Chem | Novel Sesquiterpene Glycoside from Loquat Leaf Alleviates Type 2 Diabetes Mellitus Combined with Nonalcoholic Fatty Liver Disease by Improving Insulin Resistance, Oxidative Stress, Inflammation, and Gut Microbiota Composition. | 2021 | Details |
| A01347 | 34779535 | Hepatology | Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A01348 | 34779464 | Food Funct | MUFA in metabolic syndrome and associated risk factors: is MUFA the opposite side of the PUFA coin? | 2021 | Details |
| A01367 | 34773291 | Transpl Int | A meta-analysis on the prevalence of chronic kidney disease in liver transplant candidates and its associated risk factors and outcomes. | 2021 | Details |
| A01372 | 34771745 | Cancers (Basel) | In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling. | 2021 | Details |
| A01374 | 34769488 | Int J Mol Sci | The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases. | 2021 | Details |
| A01380 | 34768539 | J Clin Med | What Do We Know about Inequalities in NAFLD Distribution and Outcomes? A Scoping Review. | 2021 | Details |
| A01387 | 34764398 | Sci Rep | A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D). | 2021 | Details |
| A01400 | 34759828 | Front Pharmacol | Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy. | 2021 | Details |
| A01401 | 34759311 | Nat Commun | Elevated circulating follistatin associates with an increased risk of type 2 diabetes. | 2021 | Details |
| A01435 | 34746842 | Curr Res Physiol | High-fat diet-associated cognitive decline: Is zinc finger protein 1 (ZPR1) the molecular connection? | 2021 | Details |
| A01444 | 34743657 | Adipocyte | Association of cell death mechanisms and fibrosis in visceral white adipose tissue with pathological alterations in the liver of morbidly obese patients with NAFLD. | 2021 | Details |
| A01463 | 34738990 | J Hypertens | Fatty liver index and hypertension-mediated organ damage in never-treated hypertensive patients without diabetes mellitus. | 2021 | Details |
| A01470 | 34736334 | Ceska Gynekol | Conservative possibilities influencing PCOS syndrome - the importance of nutrition. | 2021 | Details |
| A01485 | 34728268 | Presse Med | Complications of lipodystrophy syndromes. | 2021 | Details |
| A01504 | 34719614 | J Nutr Sci Vitaminol (Tokyo) | Effect of Hyperbaric Oxygen Therapy (HBOT) on Insulin Resistance Associated with Abdominal Obesity in Wistar Rats with Dietary Sucrose-Induced Metabolic Syndrome. | 2021 | Details |
| A01510 | 34716911 | Hormones (Athens) | Association of cardiovascular factors in diabetic patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A01513 | 34712528 | Cureus | An Emerging Facet of Diabetes Mellitus: The Nexus of Gastrointestinal Disorders. | 2021 | Details |
| A01518 | 34711595 | BMJ Open | Association between complement C3 and the prevalence of metabolic-associated fatty liver disease in a Chinese population: a cross-sectional study. | 2021 | Details |
| A01519 | 34710938 | Z Gastroenterol | Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of osteoporosis and bone fractures. | 2021 | Details |
| A01558 | 34694013 | Aliment Pharmacol Ther | Liver biopsy in the real world-reporting, expert concordance and correlation with a pragmatic clinical diagnosis. | 2021 | Details |
| A01565 | 34691178 | J Oncol | Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma. | 2021 | Details |
| A01567 | 34690658 | J Taibah Univ Med Sci | Impact of standard treatment on the quality of life of non-alcoholic fatty liver disease patients. | 2021 | Details |
| A01584 | 34684698 | Molecules | Natural Aporphine Alkaloids with Potential to Impact Metabolic Syndrome. | 2021 | Details |
| A01591 | 34684404 | Nutrients | Association between Fasting Ketonuria and Advanced Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Patients without Prediabetes and Diabetes Mellitus. | 2021 | Details |
| A01599 | 34681787 | Int J Mol Sci | The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01614 | 34679681 | Antioxidants (Basel) | Ameliorative Effect of Annona muricata (Graviola) Extract on Hyperglycemia Induced Hepatic Damage in Type 2 Diabetic Mice. | 2021 | Details |
| A01623 | 34678296 | Clin Chim Acta | The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseases. | 2021 | Details |
| A01641 | 34671102 | Nat Rev Endocrinol | Metabolic implications of pancreatic fat accumulation. | 2021 | Details |
| A01645 | 34670042 | N Engl J Med | A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH. | 2021 | Details |
| A01661 | 34663793 | Nutr Diabetes | Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD. | 2021 | Details |
| A01668 | 34660809 | J Diabetes Res | Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01671 | 34660070 | Cureus | A Retrospective Study of Hospitalizations in the USA: Proportion of Hospitalizations With Non-Alcoholic Fatty Liver Disease in Non-Obese Population. | 2021 | Details |
| A01705 | 34649307 | Clin Mol Hepatol | Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods. | 2021 | Details |
| A01710 | 34646997 | EClinicalMedicine | acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study. | 2021 | Details |
| A01720 | 34640482 | J Clin Med | Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Peripheral Diabetic Polyneuropathy: A Systematic Review and Meta-Analysis. | 2021 | Details |
| A01727 | 34638206 | Zhonghua Gan Zang Bing Za Zhi | [Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu]. | 2021 | Details |
| A01729 | 34635626 | Gut Liver | Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease. | 2022 | Details |
| A01742 | 34630901 | World J Diabetes | Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? | 2021 | Details |
| A01745 | 34630157 | Front Physiol | Effect of Exercise Training on Fat Loss-Energetic Perspectives and the Role of Improved Adipose Tissue Function and Body Fat Distribution. | 2021 | Details |
| A01755 | 34628896 | Ann Palliat Med | Accuracy of FibroTouch in assessing liver steatosis and fibrosis in patients with metabolic-associated fatty liver disease combined with type 2 diabetes mellitus. | 2021 | Details |
| A01760 | 34627696 | Nutr Metab Cardiovasc Dis | Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study. | 2021 | Details |
| A01761 | 34627692 | Nutr Metab Cardiovasc Dis | Beneficial effects of glucagon-like peptide 1 receptor agonists on glucose control, cardiovascular risk profile, and non-alcoholic fatty liver disease. An expert opinion of the Italian diabetes society. | 2021 | Details |
| A01772 | 34622192 | Metabol Open | Prevalence of elevated liver enzymes and its relationship with type 2 diabetes mellitus in North Indian adults. | 2021 | Details |
| A01773 | 34622006 | JGH Open | Effect of 48-week pemafibrate on non-alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan-aspartate aminotransferase score. | 2021 | Details |
| A01774 | 34621822 | World J Clin Cases | Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus. | 2021 | Details |
| A01775 | 34621326 | Evid Based Complement Alternat Med | A Novel Identified Peptide Hormone "Metabolitin" Attenuates Lipid Absorption in the Small Intestine of Diabetic Mice with Nonalcoholic Fatty Liver Disease by Regulating Neurotensin and AMPK Signaling Pathway. | 2021 | Details |
| A01782 | 34619105 | Lancet Diabetes Endocrinol | COVID-19 and metabolic disease: mechanisms and clinical management. | 2021 | Details |
| A01786 | 34618619 | Scand J Gastroenterol | Low awareness of non-alcoholic fatty liver disease in patients with type 2 diabetes in Swedish Primary Health Care. | 2021 | Details |
| A01789 | 34617207 | Obes Surg | Religious Fasting of Muslim Patients After Metabolic and Bariatric Surgery: a Modified Delphi Consensus. | 2021 | Details |
| A01796 | 34611618 | JHEP Rep | External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population. | 2021 | Details |
| A01800 | 34610720 | Diabetes Metab J | Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases. | 2021 | Details |
| A01811 | 34606980 | Endocr Pract | Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence From a Network Meta-Analysis of Randomized Controlled Trials. | 2021 | Details |
| A01812 | 34606913 | J Hepatol | Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus. | 2021 | Details |
| A01816 | 34606532 | Food Funct | Beneficial impacts of fermented celery (Apium graveolens L.) juice on obesity prevention and gut microbiota modulation in high-fat diet fed mice. | 2021 | Details |
| A01826 | 34603198 | Front Endocrinol (Lausanne) | Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus. | 2021 | Details |
| A01831 | 34601620 | J Gastroenterol | Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan. | 2021 | Details |
| A01850 | 34590082 | Aust J Gen Pract | Updates in fatty liver disease: Pathophysiology, diagnosis and management. | 2021 | Details |
| A01862 | 34585128 | EClinicalMedicine | The influence of equitable access policies and socioeconomic factors on post-liver transplant survival. | 2021 | Details |
| A01883 | 34573947 | Diagnostics (Basel) | Determining the Target Population That Would Most Benefit from Screening for Hepatic Fibrosis in a Primary Care Setting. | 2021 | Details |
| A01894 | 34570916 | Aliment Pharmacol Ther | Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging. | 2021 | Details |